| Mrs Bayley Renee Plumlee, MCD | |
|
100 E 9th St, Mountain Home, AR 72653-4704 | |
| (870) 404-5870 | |
| Not Available |
| Full Name | Mrs Bayley Renee Plumlee |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 100 E 9th St, Mountain Home, Arkansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528539228 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Provider Name | Healthpro Heritage Rehab & Fitness Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1235780115 PECOS PAC ID: 6507832573 Enrollment ID: O20200115000830 |
News Archive
Optimer Pharmaceuticals, Inc. announced the presentation of new data from its second fidaxomicin Phase 3 clinical study in patients with Clostridium difficile infection. The data, presented by Stuart Johnson, M.D. during an oral session at the annual meeting of Digestive Disease Week in New Orleans, indicated that treatment with fidaxomicin significantly improved the recurrence rate and global cure rate in CDI patients requiring concomitant antibiotics, compared to vancomycin.
Scientists from the Queen's University, Canada, have recently uncovered the broad-spectrum antiviral activity of epigallocatechin gallate, a bioactive compound from green tea, against highly pathogenic coronaviruses found in humans and animals. The compound prevents viral infection by interfering with virus-host cell attachment. The study is currently available on the bioRxiv* preprint server.
Research by a Sandia National Laboratories engineer and a University of New Mexico Health Sciences Center neurologist shows that brain injury may occur within one millisecond after a human head is thrust into a windshield as a result of a car accident.
An international research team has demonstrated that treating HIV-AIDS with interleukin-2 (IL-2) is ineffective. As a result, the researchers recommend that clinical trials on this compound be stopped.
Twitter users who post information about their personal health online might be considered by some to be "over-sharers," but new research led by the University of Arizona suggests that health-related tweets may have the potential to be helpful for hospitals.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Bayley Renee Plumlee, MCD 418 Browns Beach Rd, Bull Shoals, AR 72619-2809 Ph: (870) 404-9214 | Mrs Bayley Renee Plumlee, MCD 100 E 9th St, Mountain Home, AR 72653-4704 Ph: (870) 404-5870 |
News Archive
Optimer Pharmaceuticals, Inc. announced the presentation of new data from its second fidaxomicin Phase 3 clinical study in patients with Clostridium difficile infection. The data, presented by Stuart Johnson, M.D. during an oral session at the annual meeting of Digestive Disease Week in New Orleans, indicated that treatment with fidaxomicin significantly improved the recurrence rate and global cure rate in CDI patients requiring concomitant antibiotics, compared to vancomycin.
Scientists from the Queen's University, Canada, have recently uncovered the broad-spectrum antiviral activity of epigallocatechin gallate, a bioactive compound from green tea, against highly pathogenic coronaviruses found in humans and animals. The compound prevents viral infection by interfering with virus-host cell attachment. The study is currently available on the bioRxiv* preprint server.
Research by a Sandia National Laboratories engineer and a University of New Mexico Health Sciences Center neurologist shows that brain injury may occur within one millisecond after a human head is thrust into a windshield as a result of a car accident.
An international research team has demonstrated that treating HIV-AIDS with interleukin-2 (IL-2) is ineffective. As a result, the researchers recommend that clinical trials on this compound be stopped.
Twitter users who post information about their personal health online might be considered by some to be "over-sharers," but new research led by the University of Arizona suggests that health-related tweets may have the potential to be helpful for hospitals.
› Verified 7 days ago
Jordan Philip Thrasher, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3117 Partipilo St, Mountain Home, AR 72653 Phone: 501-206-4555 | |
Sarah Dewey, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1310 Bradley Dr, Mountain Home, AR 72653 Phone: 501-733-9845 | |
Bernadette Augustine Godwin, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18 County Road 458, Mountain Home, AR 72653 Phone: 870-425-5252 | |
Mollie Virginia Jane Breckenridge, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 230 Highway 5 N Ste 10, Mountain Home, AR 72653 Phone: 870-404-0270 | |
Mrs. Sarah Ellen Blagg, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2203 Russell Ln, Mountain Home, AR 72653 Phone: 870-404-5870 Fax: 870-430-5934 | |
Rebecca M Bradley, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18 County Road 458, Mountain Home, AR 72653 Phone: 870-425-5252 | |
Riley Jean Gottschalk, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 347 Hwy 62 East, College Plaza, Mountain Home, AR 72653 Phone: 870-701-5089 |